These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 29274824)

  • 1. Antituberculosis Drug-Associated DRESS: A Case Series.
    Allouchery M; Logerot S; Cottin J; Pralong P; Villier C; Ben Saïd B;
    J Allergy Clin Immunol Pract; 2018; 6(4):1373-1380. PubMed ID: 29274824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome caused by first-line antituberculosis drugs: Two case reports and a review of the literature.
    Coster A; Aerts O; Herman A; Marot L; Horst N; Kenyon C; Vlieghe E; Hainaut P; Baeck M
    Contact Dermatitis; 2019 Nov; 81(5):325-331. PubMed ID: 31021423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Difficult clinical management of antituberculosis DRESS syndrome complicated by MRSA infection: A case report.
    Wang L; Li LF
    Medicine (Baltimore); 2017 Mar; 96(11):e6346. PubMed ID: 28296768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of 3 different reintroduction regimens of antituberculosis drugs after development of antituberculosis treatment-induced hepatotoxicity.
    Sharma SK; Singla R; Sarda P; Mohan A; Makharia G; Jayaswal A; Sreenivas V; Singh S
    Clin Infect Dis; 2010 Mar; 50(6):833-9. PubMed ID: 20156055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple Drug Hypersensitivity Syndrome to Antituberculosis Drugs: A Case Report.
    Carneiro-Leão L; Gomes I; Freitas C; Costa E Silva M; Viseu R; Cernadas J
    J Investig Allergol Clin Immunol; 2020; 30(1):70-71. PubMed ID: 31530510
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug-specific CD4
    Ye YM; Hur GY; Kim SH; Ban GY; Jee YK; Naisbitt DJ; Park HS; Kim SH
    Br J Dermatol; 2017 Feb; 176(2):378-386. PubMed ID: 27373553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and Clinical Features of Drug Reactions With Eosinophilia and Systemic Symptoms Syndrome Caused by Antituberculosis Drugs: A Retrospective Cohort Study.
    Jung HY; Park S; Shin B; Lee JH; Lee SJ; Lee MK; Lee WY; Yong SJ; Kim SH
    Allergy Asthma Immunol Res; 2019 Jan; 11(1):90-103. PubMed ID: 30479080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [DRESS syndrome secondary to antituberculosis drugs: about a case].
    Jridi S; Azzeddine R; Bourkadi JE
    Pan Afr Med J; 2017; 27():37. PubMed ID: 28761613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment and management of hypersensitivity reactions developed against anti-tuberculosis drug.
    Katran ZY; Bulut I; Babalik A; Keren M
    Int J Mycobacteriol; 2022; 11(3):309-317. PubMed ID: 36260451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cure of tuberculosis despite serum concentrations of antituberculosis drugs below published reference ranges.
    Meloni M; Corti N; Müller D; Henning L; Gutteck U; von Braun A; Weber R; Fehr J
    Swiss Med Wkly; 2015; 145():w14223. PubMed ID: 26700218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antituberculosis-Drugs Induced DRESS: A Multidrug Hypersensitivity or Drug Hypersensitivity Relapse? A Case Report.
    Mansour K; Chadli Z; Ben Fadhel N; Ben Fredj N; Ben Romdhane H; Chaabane A; Toumi A; Aouam K
    Hosp Pharm; 2024 Feb; 59(1):10-14. PubMed ID: 38223863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of desensitization in the treatment of delayed drug hypersensitivities to anti-tuberculosis medications.
    Ban GY; Jeong YJ; Lee SH; Shin SS; Shin YS; Park HS; Kim SH; Ye YM
    Respir Med; 2019 Feb; 147():44-50. PubMed ID: 30704698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DRESS syndrome and acute generalized exanthematous pustulosis induced by antituberculosis medications and moxifloxacin: case report
.
    Kim H; Bang ES; Lim SK; Lee JM
    Int J Clin Pharmacol Ther; 2016 Oct; 54(10):808-15. PubMed ID: 27443659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patch testing in drug reaction with eosinophilia and systemic symptoms (DRESS): A literature review.
    de Groot AC
    Contact Dermatitis; 2022 Jun; 86(6):443-479. PubMed ID: 35233782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The "DRESS" syndrome in antituberculosis drugs].
    Bopaka RG; El Khattabi W; Afif H; Aichane A; Bouayad Z
    Rev Pneumol Clin; 2014 Jun; 70(3):185-8. PubMed ID: 24646784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of tuberculous meningitis complicated with multiple drug hypersensitivity to antituberculosis agents].
    Arai M
    Rinsho Shinkeigaku; 2015; 55(2):123-5. PubMed ID: 25746078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [DRESS syndrome induced by anti-TB drugs].
    Pavón-Romero GF; Parra-Vargas MI; Rosas-Fernández R; Ramírez-Jiménez F; Gutiérrez-Quiroz KV; Terán LM
    Rev Alerg Mex; 2023 Jun; 70(2):55-63. PubMed ID: 37566768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific features of amoxicillin-associated Drug Reaction with Eosinophilia and Systemic Symptoms syndrome: a nationwide study.
    Largeau B; Agier MS; Beau-Salinas F; Pariente A; Maruani A; Vial T; Jonville-Béra AP
    J Eur Acad Dermatol Venereol; 2021 Dec; 35(12):2415-2420. PubMed ID: 34459032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening the European pharmacovigilance database for reports of clozapine-related DRESS syndrome: 47 novel cases.
    de Filippis R; Kane JM; Kuzo N; Spina E; De Sarro G; de Leon J; De Fazio P; Schoretsanitis G
    Eur Neuropsychopharmacol; 2022 Jul; 60():25-37. PubMed ID: 35635994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.